Jemperli 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FY9XR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,356
Award facts
- Contract value 100% obligated
- $22,355.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price delivery order with a ceiling value of $22,355.67 and an ultimate completion date of September 16, 2025. The contract represents a non-competitive set-aside award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that provides global pharmaceutical and medical supply support to military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As the prime contractor on this delivery order and the underlying IDC, AmerisourceBergen demonstrates substantial capability in meeting federal medical supply requirements and supporting the DLA's strategic objective to maintain reliable, comprehensive pharmaceutical logistics for defense health operations.
Quick answers
Who was awarded contract SPE2DB25FY9XR?
SPE2DB25FY9XR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FY9XR worth?
The government has obligated $22,356 on SPE2DB25FY9XR.
Is contract SPE2DB25FY9XR an order under another contract?
Yes. SPE2DB25FY9XR is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9XR competed?
The extent of competition for SPE2DB25FY9XR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award